Phage Therapy Industry Research Report 2023

Report ID
34651
Publisher
APO Research
Published Date
11-Aug
Delivery Format
PDF
No of Report Page
108
Editor's Rating
US $2,950.00
US $4,425.00
US $5,900.00
  • Report Details
    Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
    Highlights
    The global Phage Therapy market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
    The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
    Report Scope
    This report aims to provide a comprehensive presentation of the global market for Phage Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phage Therapy.
    The Phage Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Phage Therapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
    The report will help the Phage Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
    Key Companies & Market Share Insights
    In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
        NPO Microgen
        Proteon Pharmaceuticals
        Phagelux
        Intralytix
        Micreos
        Eliava BioPreparations
        Locus Biosciences,Inc
        Pharmex Group,LLC
        Pherecydes Pharma
        APS Biocontrol Ltd. (APS)
        Qingdao Phagepharm Bio-tech
        Fixed-Phage Limited
        Zeptometrix
        Phage International, Inc.
        MicroMir
        iNtODEWORLD, Inc.
        NEXTBIOTICS
        Armata Pharmaceuticals, Inc.
        Innophage
        Adaptive Phage Therapeutics
        TechnoPhage
    Product Type Insights
    Global markets are presented by Phage Therapy type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Phage Therapy are procured by the companies.
    This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
    Phage Therapy segment by Type
        DsDNA Bacteriophage
        SsDNA Bacteriophage
        SsRNA Bacteriophage
        Others
    Application Insights
    This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
    This report also outlines the market trends of each segment and consumer behaviors impacting the Phage Therapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Phage Therapy market.
    Phage Therapy Segment by Application
        Animal Health
        Aquaculture
        Agriculture
        Food Industry
        Human Health
        Others
    Regional Outlook
    This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
    The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
        North America
            United States
            Canada
        Europe
            Germany
            France
            UK
            Italy
            Russia
            Nordic Countries
            Rest of Europe
        Asia-Pacific
            China
            Japan
            South Korea
            Southeast Asia
            India
            Australia
            Rest of Asia
        Latin America
            Mexico
            Brazil
            Rest of Latin America
        Middle East & Africa
            Turkey
            Saudi Arabia
            UAE
            Rest of MEA
    Key Drivers & Barriers
    High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
    COVID-19 and Russia-Ukraine War Influence Analysis
    The readers in the section will understand how the Phage Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
    Reasons to Buy This Report
    This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phage Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
    This report will help stakeholders to understand the global industry status and trends of Phage Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
    This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
    This report stays updated with novel technology integration, features, and the latest developments in the market
    This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Phage Therapy industry.
    This report helps stakeholders to gain insights into which regions to target globally
    This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phage Therapy.
    This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
    Core Chapters
    Chapter 1: Research objectives, research methods, data sources, data cross-validation;
    Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
    Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
    Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
    Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
    Chapter 6: Detailed analysis of Phage Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
    Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
    Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
    Chapter 13: The main points and conclusions of the report.
    Frequently Asked Questions
        What factors will challenge the Product Name market growth?
        Which end-use segment will expand at the fastest CAGR in the Product Name market?
        Which are the emerging players in the Product Name market?
        How concentrated is the Product Name market?
        Which factors are positively contributing to the Product Name market growth?
        Which are the novel product innovations in the Product Name market?
        Which product segment will emerge as the most lucrative in the Product Name market?
        Which factors are increasing the competition in the Product Name market?
        Which are the strategic measures taken by the Product Name industry players?
        Which region will witness inactive growth during the forecast period?
        What key trends are likely to emerge in the Product Name market in the coming years?
    
  • Table Of Content
    1 Preface
        1.1 Scope of Report
        1.2 Reasons for Doing This Study
        1.3 Research Methodology
        1.4 Research Process
        1.5 Data Source
            1.5.1 Secondary Sources
            1.5.2 Primary Sources
    2 Market Overview
        2.1 Product Definition
        2.2 Phage Therapy by Type
            2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
            1.2.2 DsDNA Bacteriophage
            1.2.3 SsDNA Bacteriophage
            1.2.4 SsRNA Bacteriophage
            1.2.5 Others
        2.3 Phage Therapy by Application
            2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
            2.3.2 Animal Health
            2.3.3 Aquaculture
            2.3.4 Agriculture
            2.3.5 Food Industry
            2.3.6 Human Health
            2.3.7 Others
        2.4 Assumptions and Limitations
    3 Phage Therapy Breakdown Data by Type
        3.1 Global Phage Therapy Historic Market Size by Type (2018-2023)
        3.2 Global Phage Therapy Forecasted Market Size by Type (2023-2028)
    4 Phage Therapy Breakdown Data by Application
        4.1 Global Phage Therapy Historic Market Size by Application (2018-2023)
        4.2 Global Phage Therapy Forecasted Market Size by Application (2018-2023)
    5 Global Growth Trends
        5.1 Global Phage Therapy Market Perspective (2018-2029)
        5.2 Global Phage Therapy Growth Trends by Region
            5.2.1 Global Phage Therapy Market Size by Region: 2018 VS 2022 VS 2029
            5.2.2 Phage Therapy Historic Market Size by Region (2018-2023)
            5.2.3 Phage Therapy Forecasted Market Size by Region (2024-2029)
        5.3 Phage Therapy Market Dynamics
            5.3.1 Phage Therapy Industry Trends
            5.3.2 Phage Therapy Market Drivers
            5.3.3 Phage Therapy Market Challenges
            5.3.4 Phage Therapy Market Restraints
    6 Market Competitive Landscape by Players
        6.1 Global Top Phage Therapy Players by Revenue
            6.1.1 Global Top Phage Therapy Players by Revenue (2018-2023)
            6.1.2 Global Phage Therapy Revenue Market Share by Players (2018-2023)
        6.2 Global Phage Therapy Industry Players Ranking, 2021 VS 2022 VS 2023
        6.3 Global Key Players of Phage Therapy Head office and Area Served
        6.4 Global Phage Therapy Players, Product Type & Application
        6.5 Global Phage Therapy Players, Date of Enter into This Industry
        6.6 Global Phage Therapy Market CR5 and HHI
        6.7 Global Players Mergers & Acquisition
    7 North America
        7.1 North America Phage Therapy Market Size (2018-2029)
        7.2 North America Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
        7.3 North America Phage Therapy Market Size by Country (2018-2023)
        7.4 North America Phage Therapy Market Size by Country (2024-2029)
        7.5 United States
        7.6 Canada
    8 Europe
        8.1 Europe Phage Therapy Market Size (2018-2029)
        8.2 Europe Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
        8.3 Europe Phage Therapy Market Size by Country (2018-2023)
        8.4 Europe Phage Therapy Market Size by Country (2024-2029)
        7.4 Germany
        7.5 France
        7.6 U.K.
        7.7 Italy
        7.8 Russia
        7.9 Nordic Countries
    9 Asia-Pacific
        9.1 Asia-Pacific Phage Therapy Market Size (2018-2029)
        9.2 Asia-Pacific Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
        9.3 Asia-Pacific Phage Therapy Market Size by Country (2018-2023)
        9.4 Asia-Pacific Phage Therapy Market Size by Country (2024-2029)
        8.4 China
        8.5 Japan
        8.6 South Korea
        8.7 Southeast Asia
        8.8 India
        8.9 Australia
    10 Latin America
        10.1 Latin America Phage Therapy Market Size (2018-2029)
        10.2 Latin America Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
        10.3 Latin America Phage Therapy Market Size by Country (2018-2023)
        10.4 Latin America Phage Therapy Market Size by Country (2024-2029)
        9.4 Mexico
        9.5 Brazil
    11 Middle East & Africa
        11.1 Middle East & Africa Phage Therapy Market Size (2018-2029)
        11.2 Middle East & Africa Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
        11.3 Middle East & Africa Phage Therapy Market Size by Country (2018-2023)
        11.4 Middle East & Africa Phage Therapy Market Size by Country (2024-2029)
        10.4 Turkey
        10.5 Saudi Arabia
        10.6 UAE
    12 Players Profiled
        11.1 NPO Microgen
            11.1.1 NPO Microgen Company Detail
            11.1.2 NPO Microgen Business Overview
            11.1.3 NPO Microgen Phage Therapy Introduction
            11.1.4 NPO Microgen Revenue in Phage Therapy Business (2017-2022)
            11.1.5 NPO Microgen Recent Development
        11.2 Proteon Pharmaceuticals
            11.2.1 Proteon Pharmaceuticals Company Detail
            11.2.2 Proteon Pharmaceuticals Business Overview
            11.2.3 Proteon Pharmaceuticals Phage Therapy Introduction
            11.2.4 Proteon Pharmaceuticals Revenue in Phage Therapy Business (2017-2022)
            11.2.5 Proteon Pharmaceuticals Recent Development
        11.3 Phagelux
            11.3.1 Phagelux Company Detail
            11.3.2 Phagelux Business Overview
            11.3.3 Phagelux Phage Therapy Introduction
            11.3.4 Phagelux Revenue in Phage Therapy Business (2017-2022)
            11.3.5 Phagelux Recent Development
        11.4 Intralytix
            11.4.1 Intralytix Company Detail
            11.4.2 Intralytix Business Overview
            11.4.3 Intralytix Phage Therapy Introduction
            11.4.4 Intralytix Revenue in Phage Therapy Business (2017-2022)
            11.4.5 Intralytix Recent Development
        11.5 Micreos
            11.5.1 Micreos Company Detail
            11.5.2 Micreos Business Overview
            11.5.3 Micreos Phage Therapy Introduction
            11.5.4 Micreos Revenue in Phage Therapy Business (2017-2022)
            11.5.5 Micreos Recent Development
        11.6 Eliava BioPreparations
            11.6.1 Eliava BioPreparations Company Detail
            11.6.2 Eliava BioPreparations Business Overview
            11.6.3 Eliava BioPreparations Phage Therapy Introduction
            11.6.4 Eliava BioPreparations Revenue in Phage Therapy Business (2017-2022)
            11.6.5 Eliava BioPreparations Recent Development
        11.7 Locus Biosciences,Inc
            11.7.1 Locus Biosciences,Inc Company Detail
            11.7.2 Locus Biosciences,Inc Business Overview
            11.7.3 Locus Biosciences,Inc Phage Therapy Introduction
            11.7.4 Locus Biosciences,Inc Revenue in Phage Therapy Business (2017-2022)
            11.7.5 Locus Biosciences,Inc Recent Development
        11.8 Pharmex Group,LLC
            11.8.1 Pharmex Group,LLC Company Detail
            11.8.2 Pharmex Group,LLC Business Overview
            11.8.3 Pharmex Group,LLC Phage Therapy Introduction
            11.8.4 Pharmex Group,LLC Revenue in Phage Therapy Business (2017-2022)
            11.8.5 Pharmex Group,LLC Recent Development
        11.9 Pherecydes Pharma
            11.9.1 Pherecydes Pharma Company Detail
            11.9.2 Pherecydes Pharma Business Overview
            11.9.3 Pherecydes Pharma Phage Therapy Introduction
            11.9.4 Pherecydes Pharma Revenue in Phage Therapy Business (2017-2022)
            11.9.5 Pherecydes Pharma Recent Development
        11.10 APS Biocontrol Ltd. (APS)
            11.10.1 APS Biocontrol Ltd. (APS) Company Detail
            11.10.2 APS Biocontrol Ltd. (APS) Business Overview
            11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Introduction
            11.10.4 APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2017-2022)
            11.10.5 APS Biocontrol Ltd. (APS) Recent Development
        11.11 Qingdao Phagepharm Bio-tech
            11.11.1 Qingdao Phagepharm Bio-tech Company Detail
            11.11.2 Qingdao Phagepharm Bio-tech Business Overview
            11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Introduction
            11.11.4 Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2017-2022)
            11.11.5 Qingdao Phagepharm Bio-tech Recent Development
        11.12 Fixed-Phage Limited
            11.12.1 Fixed-Phage Limited Company Detail
            11.12.2 Fixed-Phage Limited Business Overview
            11.12.3 Fixed-Phage Limited Phage Therapy Introduction
            11.12.4 Fixed-Phage Limited Revenue in Phage Therapy Business (2017-2022)
            11.12.5 Fixed-Phage Limited Recent Development
        11.13 Zeptometrix
            11.13.1 Zeptometrix Company Detail
            11.13.2 Zeptometrix Business Overview
            11.13.3 Zeptometrix Phage Therapy Introduction
            11.13.4 Zeptometrix Revenue in Phage Therapy Business (2017-2022)
            11.13.5 Zeptometrix Recent Development
        11.14 Phage International, Inc.
            11.14.1 Phage International, Inc. Company Detail
            11.14.2 Phage International, Inc. Business Overview
            11.14.3 Phage International, Inc. Phage Therapy Introduction
            11.14.4 Phage International, Inc. Revenue in Phage Therapy Business (2017-2022)
            11.14.5 Phage International, Inc. Recent Development
        11.15 MicroMir
            11.15.1 MicroMir Company Detail
            11.15.2 MicroMir Business Overview
            11.15.3 MicroMir Phage Therapy Introduction
            11.15.4 MicroMir Revenue in Phage Therapy Business (2017-2022)
            11.15.5 MicroMir Recent Development
        11.16 iNtODEWORLD, Inc.
            11.16.1 iNtODEWORLD, Inc. Company Detail
            11.16.2 iNtODEWORLD, Inc. Business Overview
            11.16.3 iNtODEWORLD, Inc. Phage Therapy Introduction
            11.16.4 iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2017-2022)
            11.16.5 iNtODEWORLD, Inc. Recent Development
        11.17 NEXTBIOTICS
            11.17.1 NEXTBIOTICS Company Detail
            11.17.2 NEXTBIOTICS Business Overview
            11.17.3 NEXTBIOTICS Phage Therapy Introduction
            11.17.4 NEXTBIOTICS Revenue in Phage Therapy Business (2017-2022)
            11.17.5 NEXTBIOTICS Recent Development
        11.18 Armata Pharmaceuticals, Inc.
            11.18.1 Armata Pharmaceuticals, Inc. Company Detail
            11.18.2 Armata Pharmaceuticals, Inc. Business Overview
            11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Introduction
            11.18.4 Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2017-2022)
            11.18.5 Armata Pharmaceuticals, Inc. Recent Development
        11.19 Innophage
            11.19.1 Innophage Company Detail
            11.19.2 Innophage Business Overview
            11.19.3 Innophage Phage Therapy Introduction
            11.19.4 Innophage Revenue in Phage Therapy Business (2017-2022)
            11.19.5 Innophage Recent Development
        11.20 Adaptive Phage Therapeutics
            11.20.1 Adaptive Phage Therapeutics Company Detail
            11.20.2 Adaptive Phage Therapeutics Business Overview
            11.20.3 Adaptive Phage Therapeutics Phage Therapy Introduction
            11.20.4 Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2017-2022)
            11.20.5 Adaptive Phage Therapeutics Recent Development
        11.21 TechnoPhage
            11.21.1 TechnoPhage Company Detail
            11.21.2 TechnoPhage Business Overview
            11.21.3 TechnoPhage Phage Therapy Introduction
            11.21.4 TechnoPhage Revenue in Phage Therapy Business (2017-2022)
            11.21.5 TechnoPhage Recent Development
    13 Report Conclusion
    14 Disclaimer
    
  • Inquiry Before Buying

    Inquiry Before Buying

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday
  • Request Sample

    Request For Sample

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday


Our Trusted Clients
cooper.fr
koronos
waldenmedical
unioncomm.co.kr
technopathclinicaldiagnostics
toho-titanium.co.jp
straubmedical
sew-eurodrive.de
medurifarms
naperol
nvent
network.ae
petronas
saeedghodran
polyworldsys
seedplanning.co.jp
kraton
ipms.fraunhofer.de
infanttech
httpswww.castel-freres
hintoninfo
hexcel
freightways.co.nz
excelitas
Acco
aspet
brand
bmc
elevate
europ-assistance


GET IN TOUCH
Phone: +1 (415) 315-9432
Phone: +91 86698 89536
connect with us